Chief of the Office of Small Business Research, NIH National Institute of Aging (NIA)
Dr. Todd Haim is Chief of the Office of Small Business Research at the National Institute of Aging (NIA). In that role, Todd manages the SBIR & STTR programs at NIA. Prior to joining NIA in 2018, Todd was a program director in the NCI SBIR Development Center. Dr. Haim managed SBIR & STTR grants and contracts focused on the development of novel cancer therapeutics and drug discovery technologies. Additionally, Todd played a key role in the planning, design, and leadership of several center initiatives, including NCI Investor Initiatives, the NCI Bridge Award, and NCI-held workshops for SBIR awardees. Prior to starting in the SBIR Development Center, he was a Research Associate and Christine Mirzayan Science and Technology Policy Fellow at the National Academy of Sciences. Dr. Haim staffed the Committee on Science, Engineering and Public Policy (COSEPUP) and his efforts centered on follow-up activities to the 2005 “Rising Above the Gathering Storm” report related to various innovation initiatives and evaluation programs. Previously, he completed a postdoctoral fellowship at Pfizer in which he actively led Pfizer’s research efforts in a collaboration with Washington University School of Medicine in St. Louis that illustrated a mechanism for altered cardiac contractility due to excess fatty acids. Dr. Haim graduated from Albert Einstein College of Medicine in January 2007 with a PhD in biomedical research and obtained a certificate in technology commercialization from John Hopkins’ Carey Business School in 2011. He has received several prestigious awards and honors including the 2014 NCI Leadership Development Award, multiple NIH and NCI Director’s Awards and the NJ Governor’s Award for Volunteerism in the Field of Health.
Lifesaving innovations do not benefit the public unless they reach the market, but achieving this task requires strategic planning and business savvy leadership. Attend this session for an in-depth discussion of what your commercialization plan should include to impress NIH reviewers. NHLBI’s entrepreneur-in-residence Gary Robinson, who brings a wealth of expertise in the development and […]